Product image of Nokdirna (Desmopressin) supplied by GNH India

Nokdirna

Active Ingredient:
Desmopressin
Origin:
EU

Nokdirna (Desmopressin)

Desmopressin, the active ingredient in Nokdirna, is a vasopressin analog presented as a sublingual formulation for sublingual use. It is employed to manage conditions characterized by excessive urine output and certain bleeding disorders.\n\nGNH India supplies Nokdirna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ferring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Desmopressin acts on the antidiuretic hormone pathway to correct water balance and improve clotting factor release.\n\nCentral diabetes insipidus: reduces excessive urine output by increasing water reabsorption in the kidneys.\nNocturnal enuresis: decreases nighttime bedwetting by concentrating urine.\nHemophilia A: raises plasma levels of factor VIII to aid clot formation.\nvon Willebrand disease: enhances release of von Willebrand factor, improving platelet adhesion.

How It Works

  • Desmopressin binds selectively to V2 receptors on the renal collecting duct cells, stimulating adenylate cyclase and raising intracellular cAMP. This cascade promotes insertion of aquaporin‑2 water channels into the apical membrane, increasing water reabsorption and concentrating urine. In the vasculature, it triggers release of stored factor VIII and von Willebrand factor from endothelial cells, supporting hemostasis.

Side Effects

  • Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Headache: mild to moderate pain often resolving without intervention.\n- Nausea: transient upset stomach or feeling of queasiness.\n- Nasal congestion: mild blockage or runny nose.\n- Mild hyponatremia: slight reduction in blood sodium that is usually asymptomatic.\n\nSerious or Rare Side Effects:\n- Severe hyponatremia: marked low sodium that can lead to confusion, seizures or coma.\n- Water intoxication: excessive fluid retention causing swelling and electrolyte imbalance.\n- Allergic reactions: rash, itching, swelling or difficulty breathing.\n- Thrombotic events: rare clot formation in blood vessels.

Precautions & Warnings

  • Desmopressin requires careful monitoring to avoid fluid and electrolyte disturbances.\n\nMonitor serum sodium: check levels regularly, especially in the elderly or those on diuretics.\nAdjust dose in renal impairment: reduce dosage if kidney function is compromised.\nCaution in elderly patients: increased susceptibility to hyponatremia and fluid overload.\nAvoid concurrent ADH analogs: additive antidiuretic effect may precipitate severe hyponatremia.\nReview fluid intake: advise patients to limit excessive water consumption.\nStore at ambient temperature: keep in the original packaging, protect from moisture and light.

Avoid Interactions

  • Desmopressin can interact with several drug classes, altering its efficacy or safety profile.\n\nMajor Interactions (Avoid):\n- Other ADH analogs: additive antidiuretic effect may cause dangerous hyponatremia.\n- MAO inhibitors: increased risk of severe hyponatremia.\n- Carbamazepine: reduces desmopressin effectiveness by enhancing its metabolism.\n\nModerate Interactions (Monitor Closely):\n- Diuretics: may exacerbate fluid and electrolyte shifts.\n- SSRIs and other antidepressants: heightened risk of hyponatremia.\n- ACE inhibitors: potential for additive sodium loss and hypotension.

Frequently Asked Questions

Nokdirna, containing desmopressin, is prescribed for central diabetes insipidus, nocturnal enuresis, hemophilia A, and von Willebrand disease. In each case the drug helps control urine output or enhances clotting factor release, addressing the underlying physiological deficit.

Desmopressin acts as an agonist at V2 receptors in the kidney collecting ducts, stimulating aquaporin‑2 channel insertion and promoting water reabsorption. It also triggers endothelial release of factor VIII and von Willebrand factor, supporting normal blood clotting.

The dose of Nokdirna is individualized by the prescribing clinician based on the specific indication, patient age, weight, renal function and response. Only a qualified health professional should determine the appropriate regimen.

Safety data for desmopressin in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a healthcare provider.

To request Nokdirna, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nokdirna is a sublingual formulation of desmopressin, offering rapid absorption and convenient administration compared with nasal sprays or injectable forms. Its efficacy in controlling urine output and enhancing clotting factors is comparable, while the sublingual route may improve patient compliance.

Nokdirna should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency.

Nokdirna is taken sublingually. The tablet or film is placed under the tongue and allowed to dissolve completely without swallowing, ensuring optimal absorption through the oral mucosa.

The most serious risks include severe hyponatremia, water intoxication, and rare allergic reactions that may lead to anaphylaxis. Patients should be monitored for signs of confusion, seizures, swelling or breathing difficulty, and treatment should be stopped immediately if these occur.

Nokdirna is contraindicated in patients with known hypersensitivity to desmopressin, uncontrolled hyponatremia, or those receiving other ADH analogs. Caution is also advised for individuals with severe renal impairment or chronic fluid overload.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Desmopressin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT